EMILY JOHN: Open Payments
NPI 1669984084 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$207 in 10 payments from 7 companies in 2025. Trend: 2023 $350 · 2024 $117 · 2025 $207
Food & beverage: $207
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Novo Nordisk Inc | 2 | $40 |
| Theratechnologies Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| ViiV Healthcare Company | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
Products named: PIFELTRO, Ozempic, FARXIGA, EGRIFTA, PREVNAR 20, BREZTRI, RUKOBIA, MOUNJARO.
Industry payments across GA — which companies pay providers there.
